AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Malin Corporation Plc

Major Shareholding Notification Jul 10, 2024

1959_mrq_2024-07-10_b7f6cca8-3314-48b9-aee3-e43d3d0ee5d9.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9338V

Malin Corporation PLC

10 July 2024

Malin Corporation plc

Holding(s) in Company

Dublin-Ireland, 10 July 2024: Malin Corporation plc. (Euronext Growth Dublin:MLC) ("Malin", the "Company"), received notification today from Mr Sean O'Driscoll  that, as of 10 July 2024, he holds an interest in 2,138,500 ordinary shares of €0.01 each which represents 11.32%* of the issued share capital of Malin.

*This percentage shareholding is based on a share in issue figure of 18,889,274 ordinary shares.

ENDS

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit  www.malinplc.com  

For further information please contact:

Malin

Fiona Dunlevy, Company Secretary

Tel: +353 (0)1 901 5700

[email protected]  

Davy Corporate Finance (Euronext Growth Listing Sponsor & Joint Broker)

Brian Garrahy / Daragh O'Reilly

Tel: +353 1 679 6363

Liberum (Joint Broker)

Phil Walker / Ben Cryer

Tel: +44 (0) 20 3100 2000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLQBLFFZDLBBBK

Talk to a Data Expert

Have a question? We'll get back to you promptly.